Australia In-Vitro Diagnostics Market is predicted to reach USD 3.12 Billion by 2030

According to the study by Next Move Strategy Consulting, the Australia In-Vitro Diagnostics Market size is predicted to reach USD 3.12 billion, at a CAGR of 6.1% by 2030.

Request a FREE Sample: https://www.nextmsc.com/australia-in-vitro-diagnostics-market/request-sample

Chronic diseases serve as a significant growth driver for the in-vitro diagnostics market in Australia.

The government investment in healthcare further serves the growth of the in-vitro diagnostics market.

The promising players operating in the Australia in-vitro diagnostics industry include Roche Holding AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Danaher Corporation, Becton, Dickinson and Company, Siemens Healthineers AG, bioMérieux SA, Sysmex Corporation, QIAGEN N.V., and Bio-Rad Laboratories, Inc., and others.